MicroRNA-16 represses granulosa cell proliferation in polycystic ovarian syndrome through inhibition of the PI3K/Akt pathway by downregulation of Apelin13

References

• Altomare, D. A., Wang, H. Q., Skele, K. L., De Rienzo, A., Klein-Szanto, A. J., Godwin, A. K., & Testa, J. R. (2004). AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene, 23(34), 5853–5857. https://doi.org/10.1038/sj.onc.1207721
   PubMed Web of Science ®Google Scholar
• Azziz, R. (2018). Polycystic Ovary Syndrome. Obstetrics and Gynecology, 132(2), 321–336. https://doi.org/10.1097/AOG.0000000000002698
   PubMed Web of Science ®Google Scholar
• Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews. Disease Primers, 2, 16057. https://doi.org/10.1038/nrdp.2016.57
   PubMed Web of Science ®Google Scholar
• Bandi, N., Zbinden, S., Gugger, M., Arnold, M., Kocher, V., Hasan, L., Kappeler, A., Brunner, T., & Vassella, E. (2009). miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Research, 69(13), 5553–5559. https://doi.org/10.1158/0008-5472.CAN-08-4277
   PubMed Web of Science ®Google Scholar
• Burja, B., Kuret, T., Janko, T., Topalović, D., Živković, L., Mrak-Poljšak, K., Spremo-Potparević, B., Žigon, P., Distler, O., Čučnik, S., Sodin-Semrl, S., Lakota, K., & Frank-Bertoncelj, M. (2019). Olive leaf extract attenuates inflammatory activation and DNA damage in human arterial endothelial cells. Frontiers in Cardiovascular Medicine, 6, 56. https://doi.org/10.3389/fcvm.2019.00056
   PubMed Web of Science ®Google Scholar
• Butz, H., & Patócs, A. (2019). MicroRNAs in endocrine tumors. EJIFCC, 30(2), 146–164. https://www.ifcc.org/ifcc-communications-publications-div
   PubMedGoogle Scholar
• Castan-Laurell, I., Dray, C., Attane, C., Duparc, T., Knauf, C., & Valet, P. (2011). Apelin, diabetes, and obesity. Endocrine, 40(1), 1–9. https://doi.org/10.1007/s12020-011-9507-9
   PubMed Web of Science ®Google Scholar
• Chen, Z., Ou, H., Wu, H., Wu, P., & Mo, Z. (2019). Role of microRNA in the pathogenesis of polycystic ovary syndrome. DNA and Cell Biology, 38(8), 754–762. https://doi.org/10.1089/dna.2019.4622
   PubMed Web of Science ®Google Scholar
• Das, M., Djahanbakhch, O., Hacihanefioglu, B., Saridogan, E., Ikram, M., Ghali, L., Raveendran, M., & Storey, A. (2008). Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 93(3), 881–887. https://doi.org/10.1210/jc.2007-1650
   PubMed Web of Science ®Google Scholar
• Ding, C. F., Chen, W. Q., Zhu, Y. T., Bo, Y. L., Hu, H. M., & Zheng, R. H. (2015). Circulating microRNAs in patients with polycystic ovary syndrome. Human Fertility, 18(1), 22–29. https://doi.org/10.3109/14647273.2014.956811
   PubMed Web of Science ®Google Scholar
• Eppig, J. J. (2001). Oocyte control of ovarian follicular development and function in mammals. Reproduction, 122(6), 829–838. https://doi.org/10.1530/rep.0.1220829
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nature Reviews. Endocrinology, 14(5), 270–284. https://doi.org/10.1038/nrendo.2018.24
   PubMed Web of Science ®Google Scholar
• Fu, X., He, Y., Wang, X., Peng, D., Chen, X., Li, X., & Wan, Q. (2018). MicroRNA-16 promotes ovarian granulosa cell proliferation and suppresses apoptosis through targeting PDCD4 in polycystic ovarian syndrome. Cellular Physiology and Biochemistry, 48(2), 670–682. https://doi.org/10.1159/000491894
   PubMedGoogle Scholar
• Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011). Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology, 7(4), 219–231. https://doi.org/10.1038/nrendo.2010.217
   PubMed Web of Science ®Google Scholar
• Gu, Y., Wang, X. D., Lu, J. J., Lei, Y. Y., Zou, J. Y., & Luo, H. H. (2015). Effect of mir-16 on proliferation and apoptosis in human A549 lung adenocarcinoma cells. International Journal of Clinical and Experimental Medicine, 8(3), 3227–3233. http://www.ijcem.com/V8_No3.html
   PubMed Web of Science ®Google Scholar
• Huang, W. (2017). MicroRNAs: Biomarkers, diagnostics, and therapeutics. Methods in Molecular Biology, 1617, 57–67. https://doi.org/10.1007/978-1-4939-7046-9_4
   PubMedGoogle Scholar
• Humplikova, L., Kollinerova, S., Papajik, T., Pikalova, Z., Holzerova, M., Prochazka, V., Divoka, M., Modriansky, M., Indrak, K., & Jarosova, M. (2013). Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 157(4), 284–293. https://doi.org/10.5507/bp.2013.057
   PubMed Web of Science ®Google Scholar
• Jiang, Y., Liu, H., Ji, B., Wang, Z., Wang, C., Yang, C., Pan, Y., Chen, J., Cheng, B., & Bai, B. (2018). Apelin-13 attenuates ER stress-associated apoptosis induced by MPP + in SH-SY5Y cells. International Journal of Molecular Medicine, 42(3), 1732–1740. https://doi.org/10.3892/ijmm.2018.3719
   PubMed Web of Science ®Google Scholar
• Kolfschoten, I. G., & Regazzi, R. (2007). Technology Insight: Small, noncoding RNA molecules as tools to study and treat endocrine diseases. Nature Clinical Practice. Endocrinology & Metabolism, 3(12), 827–834. https://doi.org/10.1038/ncpendmet0674
   PubMedGoogle Scholar
• Li, M., Zhao, H., Zhao, S. G., Wei, D. M., Zhao, Y. R., Huang, T., Muhammad, T., Yan, L., Gao, F., Li, L., Lu, G., Chan, W. Y., Leung, P. C. K., Dunaif, A., Liu, H. B., & Chen, Z. J. (2019). The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 104(4), 1049–1059. https://doi.org/10.1210/jc.2018-00544
   PubMed Web of Science ®Google Scholar
• Li, T., Mo, H., Chen, W., Li, L., Xiao, Y., Zhang, J., Li, X., & Lu, Y. (2017). Role of the PI3K-Akt Signaling pathway in the pathogenesis of polycystic ovary syndrome. Reproductive Sciences, 24(5), 646–655. https://doi.org/10.1177/1933719116667606
   PubMed Web of Science ®Google Scholar
• Li, Y., Wang, H., Zhou, D., Shuang, T., Zhao, H., & Chen, B. (2018). Up-regulation of long noncoding RNA SRA promotes cell growth, inhibits cell apoptosis, and induces secretion of estradiol and progesterone in ovarian granular cells of mice. Medical Science Monitor, 24, 2384–2390. https://doi.org/10.12659/msm.907138
   PubMed Web of Science ®Google Scholar
• Liu, G., Liu, S., Xing, G., & Wang, F. (2020). lncRNA PVT1/MicroRNA-17-5p/PTEN axis regulates secretion of E2 and P4, proliferation, and apoptosis of ovarian granulosa cells in PCOS. Molecular Therapy. Nucleic Acids, 20, 205–216. https://doi.org/10.1016/j.omtn.2020.02.007
   PubMedGoogle Scholar
• Long, W., Zhao, C., Ji, C., Ding, H., Cui, Y., Guo, X., Shen, R., & Liu, J. (2014). Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers. Cellular Physiology and Biochemistry, 33(5), 1304–1315. https://doi.org/10.1159/000358698
   PubMedGoogle Scholar
• Mabuchi, S., Kuroda, H., Takahashi, R., & Sasano, T. (2015). The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer. Gynecologic Oncology, 137(1), 173–179. https://doi.org/10.1016/j.ygyno.2015.02.003
   PubMed Web of Science ®Google Scholar
• Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E. (2014). PI3K/AKT signaling pathway and cancer: An updated review. Annals of Medicine, 46(6), 372–383. https://doi.org/10.3109/07853890.2014.912836
   PubMed Web of Science ®Google Scholar
• Mobarra, N., Shafiee, A., Rad, S. M., Tasharrofi, N., Soufi-Zomorod, M., Hafizi, M., Movahed, M., Kouhkan, F., & Soleimani, M. (2015). Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells. In Vitro Cellular & Developmental Biology. Animal, 51(6), 604–611. https://doi.org/10.1007/s11626-015-9872-4
   PubMed Web of Science ®Google Scholar
• Nandi, A., Chen, Z., Patel, R., & Poretsky, L. (2014). Polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America, 43(1), 123–147. https://doi.org/10.1016/j.ecl.2013.10.003
   PubMed Web of Science ®Google Scholar
• Peng, X., Li, F., Wang, P., Jia, S., Sun, L., & Huo, H. (2015). Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2. International Journal of Molecular Medicine, 36(3), 733–738. https://doi.org/10.3892/ijmm.2015.2265
   PubMed Web of Science ®Google Scholar
• Peng, Y., & Croce, C. M. (2016). The role of MicroRNAs in human cancer. Signal Transduction and Targeted Therapy, 1, 15004. https://doi.org/10.1038/sigtrans.2015.4
   PubMed Web of Science ®Google Scholar
• Rupaimoole, R., & Slack, F. J. (2017). MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nature Reviews. Drug Discovery, 16(3), 203–222. https://doi.org/10.1038/nrd.2016.246
   PubMed Web of Science ®Google Scholar
• Sirotkin, A. V., Laukova, M., Ovcharenko, D., Brenaut, P., & Mlyncek, M. (2010). Identification of microRNAs controlling human ovarian cell proliferation and apoptosis. Journal of Cellular Physiology, 223(1), 49–56. https://doi.org/10.1002/jcp.21999
   PubMed Web of Science ®Google Scholar
• Sirotkin, A. V., Ovcharenko, D., Grossmann, R., Laukova, M., & Mlyncek, M. (2009). Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. Journal of Cellular Physiology, 219(2), 415–420. https://doi.org/10.1002/jcp.21689
   PubMed Web of Science ®Google Scholar
• Sørensen, A. E., Wissing, M. L., Salö, S., Englund, A. L., & Dalgaard, L. T. (2014). MicroRNAs Related to Polycystic Ovary Syndrome (PCOS). Genes, 5(3), 684–708. https://doi.org/10.3390/genes5030684
   PubMed Web of Science ®Google Scholar
• Szabó, P. M., Butz, H., Igaz, P., Rácz, K., Hunyady, L., & Patócs, A. (2013). Minireview: miRomics in endocrinology: A novel approach for modeling endocrine diseases. Molecular Endocrinology, 27(4), 573–585. https://doi.org/10.1210/me.2012-1220
   PubMedGoogle Scholar
• Villavicencio, A., Goyeneche, A., Telleria, C., Bacallao, K., Gabler, F., Fuentes, A., & Vega, M. (2009). Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome. Gynecologic Oncology, 115(1), 102–107. https://doi.org/10.1016/j.ygyno.2009.06.033
   PubMed Web of Science ®Google Scholar
• Wang, C. M., Yang, X. L., Liu, M. H., Cheng, B. H., Chen, J., & Bai, B. (2018). High-throughput sequencing analysis of differentially expressed miRNAs and target genes in ischemia/reperfusion injury and apelin-13 neuroprotection. Neural Regeneration Research, 13(2), 265–271. https://doi.org/10.4103/1673-5374.226397
   PubMed Web of Science ®Google Scholar
• Wang, M., Sun, J., Xu, B., Chrusciel, M., Gao, J., Bazert, M., Stelmaszewska, J., Xu, Y., Zhang, H., Pawelczyk, L., Sun, F., Tsang, S. Y., Rahman, N., Wolczynski, S., & Li, X. (2018). Functional characterization of MicroRNA-27a-3p expression in human polycystic ovary syndrome. Endocrinology, 159(1), 297–309. https://doi.org/10.1210/en.2017-00219
   PubMed Web of Science ®Google Scholar
• Xie, F., Liu, W., Feng, F., Li, X., He, L., Lv, D., Qin, X., Li, L., Li, L., & Chen, L. (2015). Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy. Acta Biochimica et Biophysica Sinica, 47(12), 969–980. https://doi.org/10.1093/abbs/gmv111
   PubMed Web of Science ®Google Scholar
• Yang, Y., Hu, Z., Du, X., Davies, H., Huo, X., & Fang, M. (2017). miR-16 and fluoxetine both reverse autophagic and apoptotic change in chronic unpredictable mild stress model rats. Frontiers in Neuroscience, 11, 428. https://doi.org/10.3389/fnins.2017.00428
   PubMed Web of Science ®Google Scholar
• Yin, L., Zhang, P., Li, C., Si, J., Wang, Y., Zhang, X., Zhang, D., Zhang, H., & Lin, C. (2018). Apelin-13 promotes cell proliferation in the H9c2 cardiomyoblast cell line by triggering extracellular signal-regulated kinase 1/2 and protein kinase B phosphorylation. Molecular Medicine Reports, 17(1), 447–451. https://doi.org/10.3892/mmr.2017.7919
   PubMed Web of Science ®Google Scholar
• Zeng, X., Xie, Y. J., Liu, Y. T., Long, S. L., & Mo, Z. C. (2020). Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clinica Chimica Acta; International Journal of Clinical Chemistry, 502, 214–221. https://doi.org/10.1016/j.cca.2019.11.003
   PubMed Web of Science ®Google Scholar
• Zhao, C., Liu, X., Shi, Z., Zhang, J., Zhang, J., Jia, X., & Ling, X. (2015). Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Cellular Physiology and Biochemistry, 35(3), 1086–1094. https://doi.org/10.1159/000373934
   PubMedGoogle Scholar
• Zhu, Y., Xia, Y., Niu, H., & Chen, Y. (2014). MiR-16 induced the suppression of cell apoptosis while promote proliferation in esophageal squamous cell carcinoma. Cellular Physiology and Biochemistry, 33(5), 1340–1348. https://doi.org/10.1159/000358701
   PubMed Web of Science ®Google Scholar